RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.

Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.

Add to Collection
2023 Jul Others Fist_Author_Year_PM

Full Author : ['Sahay, Rakesh K', 'Giri, Richa', 'Shembalkar, Jayashree V', 'Gupta, Sandeep K', 'Mohan, Brij', 'Kurmi, Prakash', 'Kumar, S Ravindra', 'Sawardekar, Vinayak M', 'Mishra, Ashutosh', 'Murthy, L Sreenivasa', 'Arya, Vivek V', 'Sonawane, Abhijit R', 'Soni, Pravin N', 'Gofne, Sandip K', 'Karnawat, Shital R', 'Rajurkar, Mandodari N', 'Patel, Piyush M', 'Lakhwani, Lalit K', 'Mehta, Suyog C', 'Joglekar, Sadhna J']
Journal Title : Advances in therapy
Chapter : Section3
Journal Year : 2023
Cited by : Not Available

INTRODUCTION: This study compared efficacy and safety of triple drug fixed-dose combination (FDC) of dapagliflozin (DAPA) + sitagliptin (SITA) + metformin (MET) extended release (ER) with SITA + MET sustained release (SR) and DAPA + MET ER in patients wit.....

Keywords : ["type diabetes poorly control", "metformin phase randomize comparison", "dapagliflozin sitagliptin metformin", "fixeddose combination", "dual combination", "patient"]